BioSpace News Archive

Business

AquaBounty Technologies, Inc. Results for the quarter and six months ended June 30, 2018

AquaBounty Technologies, Inc. announces the Company’s financial results for the second quarter and six months ended June 30, 2018.

August 7, 2018
·
6 min read
Job Trends

CSA, OWASP Issue Updated Guidance for Secure Medical Device Deployment

Report includes enhanced sections on purchasing and mechanism controls, as well as relevant FDA guidance

August 7, 2018
·
3 min read
Business

Merrimack Reports Second Quarter 2018 Financial Results

$18 million milestone payment received from Shire; Company continues to strengthen cash position from non-dilutive sources

August 7, 2018
·
15 min read
Business

Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain

Haemonetics Corporation announced the appointment of Josep Lluis Llorens as Senior Vice President, Global Manufacturing and Supply Chain, effective August 20, 2018.

August 7, 2018
·
2 min read
Business

Bio-Techne Releases Fourth Quarter Fiscal 2018 Results

Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2018.

August 7, 2018
·
28 min read
Deals

Bio-Techne Declares Dividend Payable August 31, 2018

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2018.

August 7, 2018
·
1 min read
Business

Avanos Medical, Inc. Announces Second Quarter 2018 Results, Raises Full-Year 2018 Outlook

Avanos Medical, Inc. reported second quarter 2018 results, raised its full-year 2018 Medical Device net sales expectations and adjusted diluted earnings per share outlook.

August 7, 2018
·
52 min read
Drug Development

BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today positive results from the lead-in period of the GENESIS trial.

August 7, 2018
·
7 min read
Business

Ionis Reports Second Quarter 2018 Financial Results

Year-to-date revenues increased 15%, driven by increased SPINRAZA revenue

August 7, 2018
·
35 min read
Policy

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

Covers ApoGraft’s uses, methods and devices in stem cell selection for conditions including GvHD

August 7, 2018
·
5 min read